AAO 2024: New gene therapy shows promise for treatment of …
2024年10月20日 · Key Takeaways. MCO-010 gene therapy improves vision in retinitis pigmentosa patients, with up to 50% gaining significant visual acuity. The therapy is mutation …
Ophthalmology Times - Ophthalmology news, articles, and events
Panelists discuss how the Port Delivery System (PDS) presents important considerations around adverse effects, patient selection criteria, and adoption challenges including surgical …
AAO 2024: Long-term low-dose antiviral treatment benefits …
2024年10月19日 · Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles …
What your patients need to know about eye color-changing drops
2024年8月28日 · The American Academy of Ophthalmology indicates that consumers who may see the eye color-changing drops advertised and used on TikTok or elsewhere online should …
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
2024年10月14日 · Key Takeaways. enVista Envy IOLs provide a continuous range of vision with high dysphotopsia tolerance, enhancing cataract surgery outcomes. U.S. and Canadian trials …
ASCRS 2024: What advancements in Light Adjustable Lens …
2024年4月10日 · Neda Nikpoor, MD, spoke to Ophthalmology Times about her presentation on the Light Adjustable Lens during an ASCRS symposia on IOL calculations.. Video Transcript. …
Teprotumumab: TED treatment shows benefits for patients
2024年11月18日 · References: Ugradar S, Parunakian E, Malkhasyan E, et al. The rate of re-treatment in patients treated with teprotumumab: a multicenter study of 119 patients with 1 …
Advancing Fuchs dystrophy care: Longterm success of descemet …
2024年12月26日 · Deepinder Dhaliwal, MD, LAc, explores advancements in managing Fuchs endothelial corneal dystrophy, highlighting Descemet stripping only (DSO). Long-term …
What increased depth of focus can mean to your monofocal IOL …
2024年12月31日 · Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice for patients seeking improved distance …
AAO 2024: Clinical updates on Neurotech's NT-501
2024年10月18日 · Key Takeaways. NT-501 shows promise in sustained CNTF delivery, offering long-term therapy without frequent interventions for MacTel patients. Bilateral safety data from …